Intriguingly, in spleen tissues derived from SCC7 subcutaneous transplant tumor model, the combination treatment resulted in a significant reduction in macrophages within the CD45+ immune cell population (Fig. 3K). This evidence concerns the gene PTPRC and neoplasm.